<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31764246</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>26</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>How Soon Should Patients With Colon Cancer Undergo Definitive Resection?</ArticleTitle><Pagination><StartPage>172</StartPage><EndPage>182</EndPage><MedlinePgn>172-182</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000001525</ELocationID><Abstract><AbstractText Label="BACKGROUND">Timing of surgery has been shown to affect outcomes in many forms of cancer, but definitive national data do not exist to determine the effect of time to surgery on survival in colon cancer.</AbstractText><AbstractText Label="OBJECTIVE">This study aimed to determine whether a delay in definitive surgery in colon cancer significantly affects survival.</AbstractText><AbstractText Label="DATA SOURCES">A retrospective cohort study using 2 independent population-based databases, The Surveillance, Epidemiology, and End Results Medicare-linked database and the National Cancer Database, was performed.</AbstractText><AbstractText Label="STUDY SELECTION">All patients had American Joint Committee on Cancer stage 1 through 3 colon cancer. Patients were more than 18 years of age in the National Cancer Database cohort and older than 66 years of age in the Medicare cohort. Patients had a minimum of 3 years of follow-up.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">The main outcome was overall survival as a function of time between diagnosis and surgery in 4 intervals (1-2, 3-4, 5-6, &gt;6 weeks).</AbstractText><AbstractText Label="RESULTS">The Medicare cohort demonstrated an adjusted 5-year survival of 8% to 14% higher in patients with a surgical delay between 3 and 6 weeks, with significantly lower hazard ratios in that interval. The National Cancer Database cohort demonstrated an adjusted 5-year survival of 9% to 16% higher in patients with surgery 3 to 6 weeks after diagnosis, with comparatively similar improvements in survival hazard.</AbstractText><AbstractText Label="LIMITATIONS">Because this was a retrospective study of administrative databases, with Medicare data limited to billing data, the causality of outcomes must be interpreted with caution.</AbstractText><AbstractText Label="CONCLUSIONS">The ideal timing of definitive resection in colon cancer is between 3 and 6 weeks after initial diagnosis. All efforts should be made for patients to obtain definitive surgery within this interval to achieve a modest but significant improvement in overall survival. See Video Abstract at http://links.lww.com/DCR/B76. &#xbf;CU&#xc1;NDO DEBEN SOMETERSE LOS PACIENTES CON C&#xc1;NCER DE COLON A UNA RESECCI&#xd3;N DEFINITIVA?: Se ha demostrado que el momento de la cirug&#xed;a afecta los resultados en muchas formas de c&#xe1;ncer, pero no existen datos nacionales definitivos para determinar el efecto del tiempo hasta la cirug&#xed;a en la supervivencia en el c&#xe1;ncer de colon.Determinar si un retraso en la cirug&#xed;a definitiva en el c&#xe1;ncer de colon afecta significativamente la supervivencia.Un estudio de cohorte retrospectivo que utiliza dos bases de datos independientes basadas en la poblaci&#xf3;n; Se realiz&#xf3; la base de datos vinculada a la vigilancia, la epidemiolog&#xed;a y los resultados finales y la base de datos nacional del c&#xe1;ncer.Pacientes con c&#xe1;ncer de colon en estad&#xed;os 1 a 3 del Comit&#xe9; Estadounidense Conjunto sobre el C&#xe1;ncer. Los pacientes ten&#xed;an m&#xe1;s de 18 a&#xf1;os en la cohorte de la National Cancer Database y m&#xe1;s de 66 a&#xf1;os en la cohorte de Medicare. Los pacientes tuvieron un m&#xed;nimo de 3 a&#xf1;os de seguimiento.El resultado principal fue la supervivencia general en funci&#xf3;n del tiempo entre el diagn&#xf3;stico y la cirug&#xed;a en 4 intervalos (1-2, 3-4, 5-6, y mas de 6 semanas).La cohorte de Medicare demostr&#xf3; una supervivencia ajustada de 5 a&#xf1;os de 8 a 14% m&#xe1;s en pacientes con un retraso quir&#xfa;rgico entre 3 a 6 semanas, con razones de riesgo significativamente m&#xe1;s bajas en ese intervalo. La cohorte de la National Cancer Database demostr&#xf3; una supervivencia ajustada a 5 a&#xf1;os de 9 a 16% m&#xe1;s en pacientes con cirug&#xed;a de 3 a 6 semanas despu&#xe9;s del diagn&#xf3;stico, con mejoras comparativamente similares en el riesgo de supervivencia.Dado que este fue un estudio retrospectivo de bases de datos administrativas, con datos de Medicare limitados a datos de facturaci&#xf3;n, la causalidad de los resultados debe interpretarse con precauci&#xf3;n.El momento ideal para la resecci&#xf3;n definitiva en el c&#xe1;ncer de colon es entre tres y seis semanas despu&#xe9;s del diagn&#xf3;stico inicial. Se deben hacer todos los esfuerzos para que los pacientes obtengan una cirug&#xed;a definitiva dentro de este intervalo para lograr una mejora modesta pero significativa en la supervivencia general. Consulte Video Resumen en http://links.lww.com/DCR/B76.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kucejko</LastName><ForeName>Robert J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, Drexel University College of Medicine, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holleran</LastName><ForeName>Timothy J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, Drexel University College of Medicine, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stein</LastName><ForeName>David E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Department of Surgery, Drexel University College of Medicine, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poggio</LastName><ForeName>Juan L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Division of Colorectal Surgery, Department of Surgery, Drexel University College of Medicine, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D057405">Webcast</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000359" MajorTopicYN="N">Aftercare</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003082" MajorTopicYN="N">Colectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003110" MajorTopicYN="N">Colonic Neoplasms</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006278" MajorTopicYN="N">Medicare</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061665" MajorTopicYN="N">Time-to-Treatment</DescriptorName><QualifierName UI="Q000941" MajorTopicYN="Y">ethics</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31764246</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000001525</ArticleId><ArticleId IdType="pii">00003453-202002000-00008</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Howlader N, Noone AM, Krapcho M. SEER Cancer Statistics Review (CSR) 1975&#x2013;2014. Bethesda, MD: National Cancer Institute. Available at: https://seer.cancer.gov/csr/1975_2014/. Accessed June 8, 2018.</Citation></Reference><Reference><Citation>Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67:177&#x2013;193.</Citation></Reference><Reference><Citation>Vogel JD, Eskicioglu C, Weiser MR, Feingold DL, Steele SR. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Treatment of Colon Cancer. Dis Colon Rectum. 2017;60:999&#x2013;1017.</Citation></Reference><Reference><Citation>National Comprehensive Cancer Network. Colon Cancer (Version 2.2017). Available at: https//:www.nccn.org/professionals/physician_gls/pdf/colon.pdf. Accessed June 8, 2018.</Citation></Reference><Reference><Citation>Aquina CT, Becerra AZ, Xu Z, et al. Nonelective colon cancer resection: a continued public health concern. Surgery. 2017;161:1609&#x2013;1618.</Citation></Reference><Reference><Citation>Paulson EC, Mahmoud NN, Wirtalla C, Armstrong K. Acuity and survival in colon cancer surgery. Dis Colon Rectum. 2010;53:385&#x2013;392.</Citation></Reference><Reference><Citation>Bakker IS, Snijders HS, Grossmann I, Karsten TM, Havenga K, Wiggers T. High mortality rates after nonelective colon cancer resection: results of a national audit. Colorectal Dis. 2016;18:612&#x2013;621.</Citation></Reference><Reference><Citation>Xu Z, Becerra AZ, Aquina CT, et al. Emergent colectomy is independently associated with decreased long-term overall survival in colon cancer patients. J Gastrointest Surg. 2017;21:543&#x2013;553.</Citation></Reference><Reference><Citation>Bleicher RJ, Ruth K, Sigurdson ER, et al. Time to surgery and breast cancer survival in the United States. JAMA Oncol. 2016;2:330&#x2013;339.</Citation></Reference><Reference><Citation>Amri R, Bordeianou LG, Sylla P, Berger DL. Treatment delay in surgically-treated colon cancer: does it affect outcomes? Ann Surg Oncol. 2014;21:3909&#x2013;3916.</Citation></Reference><Reference><Citation>Iversen LH, Green A, Ingeholm P, &#xd8;sterlind K, G&#xf6;genur I. Improved survival of colorectal cancer in Denmark during 2001&#x2013;2012 &#x2013; The efforts of several national initiatives. Acta Oncol. 2016;55(suppl 2):10&#x2013;23.</Citation></Reference><Reference><Citation>Kim SI, Park BW, Lee KS. Comparison of stage-specific outcome of breast cancer based on 5th and 6th AJCC staging system. J Surg Oncol. 2006;93:221&#x2013;227.</Citation></Reference><Reference><Citation>Lunceford JK, Davidian M. Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study. Stat Med. 2004;23:2937&#x2013;2960.</Citation></Reference><Reference><Citation>Thoemmes F. Propensity score matching in SPSS. 2012. Tubingen, Germany: University of Tubingen; Available at: http://arxiv.org/ftp/arxiv/papers/1201/1201.6385.pdf. Accessed June 8, 2018.</Citation></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373&#x2013;383.</Citation></Reference><Reference><Citation>Lerro CC, Robbins AS, Phillips JL, Stewart AK. Comparison of cases captured in the national cancer data base with those in population-based central cancer registries. Ann Surg Oncol. 2013;20:1759&#x2013;1765.</Citation></Reference><Reference><Citation>Schneider EB, Hyder O, Brooke BS, et al. Patient readmission and mortality after colorectal surgery for colon cancer: impact of length of stay relative to other clinical factors. J Am Coll Surg. 2012;214:390&#x2013;398.</Citation></Reference><Reference><Citation>Chang GJ, Kaiser AM, Mills S, Rafferty JF, Buie WD; Standards Practice Task Force of the American Society of Colon and Rectal Surgeons. Practice parameters for the management of colon cancer. Dis Colon Rectum. 2012;55:831&#x2013;843.</Citation></Reference><Reference><Citation>Moreno CC, Mittal PK, Sullivan PS, et al. Colorectal cancer initial diagnosis: screening colonoscopy, diagnostic colonoscopy, or emergent surgery, and tumor stage and size at initial presentation. Clin Colorectal Cancer. 2016;15:67&#x2013;73.</Citation></Reference><Reference><Citation>Gillis C, Buhler K, Bresee L, et al. Effects of nutritional prehabilitation, with and without exercise, on outcomes of patients who undergo colorectal surgery: a systematic review and meta-analysis. Gastroenterology. 2018;155:391&#x2013;410.e4.</Citation></Reference><Reference><Citation>Jie B, Jiang ZM, Nolan MT, Zhu SN, Yu K, Kondrup J. Impact of preoperative nutritional support on clinical outcome in abdominal surgical patients at nutritional risk. Nutrition. 2012;28:1022&#x2013;1027.</Citation></Reference><Reference><Citation>Truong A, Hanna MH, Moghadamyeghaneh Z, Stamos MJ. Implications of preoperative hypoalbuminemia in colorectal surgery. World J Gastrointest Surg. 2016;8:353&#x2013;362.</Citation></Reference><Reference><Citation>Gonzalez-Saenz de Tejada M, Bilbao A, Bar&#xe9; M, et al.; CARESS-CCR Group. Association between social support, functional status, and change in health-related quality of life and changes in anxiety and depression in colorectal cancer patients. Psychooncology. 2017;26:1263&#x2013;1269.</Citation></Reference><Reference><Citation>Kuhnen AH, Marcello PW, Roberts PL, et al. Can the national surgical quality improvement program provide surgeon-specific outcomes? Dis Colon Rectum. 2015;58:247&#x2013;253.</Citation></Reference><Reference><Citation>Waters JA, Francone T, Marcello PW, et al. quality improvement initiatives in colorectal surgery: value of physician feedback. Dis Colon Rectum. 2017;60:213&#x2013;218.</Citation></Reference><Reference><Citation>Sandar M, Hsiang LG, Yew CK, Guat LB. Use of population-based cancer registry data to determine the effect of timely treatment on the survival of colorectal cancer patients. J Registry Manag. 2015;42:130&#x2013;138.</Citation></Reference><Reference><Citation>Myers RE, Sifri R, Daskalakis C, et al. Increasing colon cancer screening in primary care among African Americans. J Natl Cancer Inst. 2014; 106:dju344</Citation></Reference><Reference><Citation>Gill AA, Enewold L, Zahm SH, et al. Colon cancer treatment: are there racial disparities in an equal-access healthcare system? Dis Colon Rectum. 2014;57:1059&#x2013;1065.</Citation></Reference><Reference><Citation>Penn DC, Chang Y, Meyer AM, et al. Provider-based research networks may improve early access to innovative colon cancer treatment for African Americans treated in the community. Cancer. 2015;121:93&#x2013;101.</Citation></Reference><Reference><Citation>Landrum MB, Keating NL, Lamont EB, Bozeman SR, McNeil BJ. Reasons for underuse of recommended therapies for colorectal and lung cancer in the Veterans Health Administration. Cancer. 2012;118:3345&#x2013;3355.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29501284</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2173-5727</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>5</Issue><PubDate><Year>2018</Year><Season>Jun-Jul</Season></PubDate></JournalIssue><Title>Medicina intensiva</Title><ISOAbbreviation>Med Intensiva (Engl Ed)</ISOAbbreviation></Journal><ArticleTitle>Analysis of causality from observational studies and its application in clinical research in Intensive Care Medicine.</ArticleTitle><Pagination><StartPage>292</StartPage><EndPage>300</EndPage><MedlinePgn>292-300</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.medin.2018.01.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0210-5691(18)30009-3</ELocationID><Abstract><AbstractText>Random allocation of treatment or intervention is the key feature of clinical trials and divides patients into treatment groups that are approximately balanced for baseline, and therefore comparable covariates except for the variable treatment of the study. However, in observational studies, where treatment allocation is not random, patients in the treatment and control groups often differ in covariates that are related to intervention variables. These imbalances in covariates can lead to biased estimates of the treatment effect. However, randomized clinical trials are sometimes not feasible for ethical, logistical, economic or other reasons. To resolve these situations, interest in the field of clinical research has grown in designing studies that are most similar to randomized experiments using observational (i.e. non-random) data. Observational studies using propensity score analysis methods have been increasing in the scientific papers of Intensive Care. Propensity score analyses attempt to control for confounding in non-experimental studies by adjusting for the likelihood that a given patient is exposed. However, studies with propensity indexes may be confusing, and intensivists are not familiar with this methodology and may not fully understand the importance of this technique. The objectives of this review are: to describe the fundamentals of propensity index methods; to present the techniques to adequately evaluate propensity index models; to discuss the advantages and disadvantages of these techniques.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier Espa&#xf1;a, S.L.U. y SEMICYUC. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Coscia Requena</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Unidad de Bioestad&#xed;stica, Hospital Universitario Ram&#xf3;n y Cajal, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muriel</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unidad de Bioestad&#xed;stica, Hospital Universitario Ram&#xf3;n y Cajal, Madrid, Espa&#xf1;a; IRYCIS. CIBER de Epidemiolog&#xed;a (CIBERESP), Madrid, Espa&#xf1;a; Departamento de Enfermer&#xed;a y Fisioterapia, Universidad de Alcal&#xe1;, Alcal&#xe1; de Henares, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pe&#xf1;uelas</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Unidad de Cuidados Intensivos y Grandes Quemados, Hospital Universitario de Getafe, Getafe, Madrid, Espa&#xf1;a; CIBER de Enfermedades Respiratorias (CIBERES), Espa&#xf1;a. Electronic address: oscar.penuelasro@salud.madrid.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>An&#xe1;lisis de la causalidad desde los estudios observacionales y su aplicaci&#xf3;n en la investigaci&#xf3;n cl&#xed;nica en Cuidados Intensivos.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Med Intensiva (Engl Ed)</MedlineTA><NlmUniqueID>101717568</NlmUniqueID><ISSNLinking>2173-5727</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="Y">Biomedical Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015984" MajorTopicYN="Y">Causality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="Y">Critical Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="Y">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="Y">Propensity Score</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Causalidad</Keyword><Keyword MajorTopicYN="N">Causality</Keyword><Keyword MajorTopicYN="N">Clinical trial</Keyword><Keyword MajorTopicYN="N">Confounders</Keyword><Keyword MajorTopicYN="N">Confusi&#xf3;n</Keyword><Keyword MajorTopicYN="N">Cuidados Intensivos</Keyword><Keyword MajorTopicYN="N">Ensayo cl&#xed;nico</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Epidemiolog&#xed;a</Keyword><Keyword MajorTopicYN="N">Estudio observacional</Keyword><Keyword MajorTopicYN="N">Intensive Care</Keyword><Keyword MajorTopicYN="N">Observational study</Keyword><Keyword MajorTopicYN="N">Propensity score</Keyword><Keyword MajorTopicYN="N">Propensi&#xf3;n</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29501284</ArticleId><ArticleId IdType="doi">10.1016/j.medin.2018.01.002</ArticleId><ArticleId IdType="pii">S0210-5691(18)30009-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>